Could another possible reason for the speedy settlement be that GSK are looking to licence LANI?
It makes sense, a possible billion dollar deal for Biota/Sankyo that is currently being held back by the Relenza litigation?!?!?!?
Any thoughts?
Add to My Watchlist
What is My Watchlist?